Keio University

Completion of the Clinical Study: A Safety Trial of Allogeneic iPS Cell–Derived Regenerated Cardiomyocyte Spheroid Transplantation in Patients with Refractory Severe Heart Failure

Publish: February 20, 2024
School of Medicine/Graduate School of Medicine